Magsoothium Cbd Cooling Roll on Relief

Description

Broad Spectrum Hemp CBD is formulated as a cooling roll-on relief product. It is presented in a net volume of 3 fluid ounces (89 milliliters). This product is designed for topical application, leveraging the properties of broad-spectrum hemp extract to provide relief.

Uses and Indications

Broad Spectrum Hemp CBD is indicated for use as a Cooling Roll On Relief.

There are no teratogenic or nonteratogenic effects associated with this product.

Dosage and Administration

For adults and children over the age of 2 years, the recommended application is to apply the product generously to the affected area, using gentle rubbing, 2 to 3 times daily or as needed.

For children under the age of 2 years, it is advised to consult a healthcare professional prior to use.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence. Additionally, there are no specific instructions indicating that the product should not be taken or used under any circumstances.

Warnings and Precautions

For external use only, this product must be utilized strictly as directed. It is imperative that the area being treated is not bandaged or covered, and the application of ice or heating pads in conjunction with this product is contraindicated. The use of this product with any medical device or other devices is prohibited, as is the combination with any other topical treatments. Care should be taken to avoid contact with the eyes or mucous membranes, and the product should not be applied to wounds or damaged skin.

General precautions include ensuring that the product is kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

No specific laboratory tests or emergency medical help instructions are provided in the insert. Additionally, there are no defined instructions regarding when to stop using the product and contact a healthcare provider.

Side Effects

Patients using this product should be aware of several important warnings and precautions to minimize the risk of adverse reactions. This product is intended for external use only and should be used strictly as directed. It is crucial that patients do not bandage or cover the area being treated, as this may lead to increased risk of adverse effects.

Additionally, patients should refrain from applying ice or heating pads in conjunction with this product, as this may exacerbate irritation or other adverse reactions. The use of this product with any medical device or other topical treatments is not recommended, as such combinations may lead to unforeseen complications.

Contact with the eyes or mucous membranes should be avoided to prevent irritation or injury. Furthermore, this product should not be applied to wounds or damaged skin, as this may increase the likelihood of adverse reactions. Adhering to these guidelines is essential for ensuring patient safety and minimizing the risk of adverse effects associated with the use of this product.

Drug Interactions

The use of this medication is contraindicated in conjunction with any medical device or other device. Additionally, it should not be combined with any other topical treatment, as such combinations may lead to unforeseen adverse effects or diminished therapeutic efficacy.

There are no specific interactions identified with laboratory tests associated with this medication. Therefore, routine monitoring of laboratory parameters is not required in the context of drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Magsoothium Cbd Cooling Roll on Relief (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients over the age of 2 years may apply the medication generously with gentle rubbing to the affected area 2-3 times daily or as needed. For children less than 2 years of age, it is advised to consult a doctor prior to use.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population, given the lack of targeted data.

Pregnancy

There is no specific information regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment and the need to inform their healthcare provider if they become pregnant or plan to become pregnant while on this medication.

Lactation

Nursing mothers should consult a doctor before using this product. There is a potential for excretion in breast milk, and the safety of this product during lactation has not been established. Caution is advised when using this product while breastfeeding.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide further management and treatment options.

Documentation of the incident, including the substance involved, the amount taken, and the time of ingestion, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. In the event of accidental ingestion, patients should be instructed to seek medical help or contact a Poison Control Center immediately. It is important for patients to understand the potential risks associated with improper use and to take necessary precautions to ensure safety.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which are essential for identification and inventory management. It is recommended to store the product at room temperature to maintain its efficacy.

To ensure optimal preservation, the product must be protected from light exposure. Additionally, it is crucial to keep the container tightly closed when not in use to prevent contamination and degradation. It is advised to discard the product after opening if it is not utilized within the specified time frame, although the exact duration is not provided in the available information.

Additional Clinical Information

The medication is administered topically. For adults and children over the age of 2 years, it should be applied generously with gentle rubbing to the affected area 2-3 times daily or as needed. For children under 2 years of age, consultation with a doctor is advised prior to use.

No further information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Magsoothium Cbd Cooling Roll on Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)